- Home
- Equipment
- usa massachusetts
- drug resistant
Refine by
Drug Resistant Equipment Supplied In Usa Massachusetts
5 equipment items found
Manufactured by:Vedanta Biosciences, Inc based inCambridge, MASSACHUSETTS (USA)
VE707 is a preclinical discovery program for the prevention of infection and colonization recurrence of several multi-drug resistant organisms (MDROs) including carbapenem-resistant Enterobacteriaceae (CRE), extended-spectrum beta lactamase producers (ESBL), and vancomycin-resistant Enterococci (VRE), which are some of the most ...
Manufactured by:Third Pole Therapeutics, Inc. based inWaltham, MASSACHUSETTS (USA)
Nitric Oxide…. Created From The Air We Breathe And Electricity. Innovative technology and highly sophisticated engineering that advances the field of inhaled NO by creating a portable and miniaturized platform technology to generate inhaled Nitric Oxide (iNO) on demand, accurately, safely, and reliably and maximize the well-established clinical benefits of iNO through highly differentiated ...
Manufactured by:Mersana Therapeutics based inCambridge, MASSACHUSETTS (USA)
Once ADCs release their cytotoxic payload into targeted cells, the drug is often able to cross cell membranes, entering and potentially killing neighboring cells whether those cells are cancerous or not. This effect is called bystander-killing, which is advantageous when bystander cells are cancerous but toxic if the cytotoxic drug is able to enter adjacent healthy cells. The DolaLock payload ...
Manufactured by:MorphoSys AG based inPlanegg, GERMANY
Tulmimetostat is a second-generation EZH2 inhibitor that has been designed to achieve comprehensive target coverage through extended on-target residence time. EZH2 acts as an epigenetic writer and normally places one or more methyl groups on a histone protein, leading to the suppression of gene expression. Some cancers depend on an abnormal pattern of gene expression and re-direct EZH2 to genes ...
by:T2 Biosystems, Inc. based inLexington, MASSACHUSETTS (USA)
The first direct-from-blood detection of resistance markers: The T2Resistance® Panel is designed for the direct-from-blood detection of antibiotic resistance genes associated with sepsis-causing pathogens. The Panel detects many of the resistance mechanisms described in the 2013 CDC Urgent Threat list. In 2019, the FDA granted “Breakthrough Device” designation for the T2Resistance ...